Product display

Hyperthermia machine
Regional treatment for deep-seated tumors and inflammation by physical and biological selectivity.Noninvasive, painless, regional non-invasive treatment with adjuvant radiotherapy and chemotherapy are more sensitized and synergized; noticeably relieve pain from intractable cancer.
020-32293435

What is CT-Ⅱ RF-Capacitive Hyperthermia?
CT-Ⅱ RF-Capacitive Hyperthermia is an Armarium which adopts the method of non-invasive modality to cure the disease in deep tissue and organ. The machine uses a Uniform heating electromagnetic field with a frequency of 13.56MHz to act on organs. Thermal effect can lead to the hemangiectasis of local tissue, increase the permeability of histocyte, fast the circulation of blood, enrich the nutrition of tissue and promote the excretion of metabolite, so as to cure the disease. The noninvasive, painless, regional non-invasive treatment with adjuvant radiotherapy and chemotherapy are more sensitized and synergized; noticeably relieve pain from intractable cancer.
Applications
Regional treatment for deep-seated tumors and inflammation by physical and biological selectivity.
●Gynaecological malignancies and inflammation (e.g. breast, ovary, cervix Chronic PID etc.)
●Physical Therapy Branch ( e.g. arthritis, rheumatoid etc.)
● Urology (e.g. Chronic prostatitis, prostate cancer, bladder cancer etc.)
● Malignant tumors in organs
● Deep seated cancer lesions (e.g. brain, liver, lung, kidney, pancreas, etc.)
● Lymph node metastases
● Gastrointestinal tumors (e. g. esophagus, colon etc.)
● Sarcomas, melanomas, basaliomas, etc.
Effects
●Thermal damage of tumor cells
● Acidic poisoning of the malignant tissue
● Inhibition of repair mechanism
●Potentiation of chemo- and radiotherapy
●Stimulation of the immune system
Feature

●Non-invasive treatment
●Focuses automatically on tumor tissue
●Suitable for in- and outpatient treatment
● Painless and free of side effects
●Significant gain of life-quality

 

 

Clinical scope
As adjuvant therapy, hyperthermia combined with tumor radiotherapy and chemotherapy for hepatic carcinoma, bladder Cancer, etc.
Clinical advantages
Patient prefer non-invasive, painless treatment that makes clinical treatment easier.
Depth of up to 25cm high frequent penetration available treated all kind of body cavity tumor.
To integrate high frequent adjuvant radiotherapy with chemotherapy achieves sensitized and synergized aggregate effect.
Conspicuously relieve pain from intractable cancer, specifically for malignant pleural effusion and ascites
Clinical cases
Profiles: 94 cases of cancer patients, included 39 esophageal carcinomas, 26 lung cancers, 11 gastric carcinomas, 8 lung metastatic breast cancers, each 5 cases of hepatic carcinomas and rectal cancers. Among these patients, 29 were local relapse after operation and complicated by widely thoracic cavity or peritoneal metastatic, 17 never subject to operation but also the advanced cancer like 29 patients.
Therapy: Develop programs based on different patient condition and tissue types. Select fluorouracil, cisplatin, cyclophosphamide, doxorubicin, etc. as chemotherapy medicine. Intravenous infusion 3 hours before or simultaneously with hyperthermia. Treatment time: 60-90min each time, 1 time/d, 5-10d as one treatment course.
Results:
1.Clinical efficacy: CR (Complete remission) 10 cases, PR (partial remission) 57 cases, NC (No change) 27 cases. Total effective rate(CR+PR): 71% (67/94)
2.Toxic side effects: Myelosuppression (94 cases): No leukopenia to 2.0 × 109 / L or less, and no reduction in red blood cells and platelets. All cases were not found toxic side effects in liver and kidney.